VitaSpring Biomedical Co. Ltd.
VSBC
$0.01
-$0.24-95.56%
OTC PK
| 10/31/2023 | 07/31/2023 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -33.54% | 16.09% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -33.54% | 16.09% | |||
| Operating Income | 33.54% | -16.09% | |||
| Income Before Tax | 33.54% | -16.09% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 33.54% | -16.09% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 33.54% | -16.09% | |||
| EBIT | 33.54% | -16.09% | |||
| EBITDA | 33.91% | -16.29% | |||
| EPS Basic | 35.29% | -13.33% | |||
| Normalized Basic EPS | 36.36% | -22.22% | |||
| EPS Diluted | 35.29% | -13.33% | |||
| Normalized Diluted EPS | 36.36% | -22.22% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||